Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Jia S, Zhou W, Wu J, Liu X, Guo S, Zhang J, Zhang X (2020) A biomolecular network-based strategy deciphers the underlying molecular mechanisms of Bupleuri Radix/Curcumae Radix medicine pair in the treatment of hepatitis C. Eur J Integ Med 33:101043
2. El-Kassem LA, Hawas UW, El-Souda S, Ahmed EF, El-Khateeb W, Fayad W (2019) Anti-HCV protease potential of endophytic fungi and cytotoxic activity. Biocatal Agric Biotechnol 19:101170
3. González-Grande R, Jiménez-Pérez M, Arjona CG, Torres JM (2016) New approaches in the treatment of hepatitis C. World J Gastroenterol 22(4):1421
4. Kucherenko A, Pampukha V, Romanchuk KY, Chernushyn SY, Bobrova I, Moroz L, Livshits L (2016) IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients. Cytol Genet 50(5):330–333
5. World Health Organization (2018) Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva. Licence: CC BY-NC-SA 3.0 IGO. WHO, Geneva